BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Interrelationship of Runx2 and estrogen pathway in skeletal tissues

  • Jeong, Jae-Hwan (Department of Biochemistry and Cell Biology, School of Medicine, WCU Program, Kyungpook National University) ;
  • Choi, Je-Yong (Department of Biochemistry and Cell Biology, School of Medicine, WCU Program, Kyungpook National University)
  • Received : 2011.09.26
  • Published : 2011.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Two key molecules in skeletal tissues are bone formation master transcription factor Runx2 and the steroid hormone estrogen. It is well known that these two molecules play pivotal roles in bone homeostasis; however, the functional interaction between Runx2 and estrogen synthesis in skeletal tissues is largely unknown. Recent studies have indicated that there is a positive relationship between Runx2 and the estrogen biosynthesis pathway. In this review, a possible functional link between Runx2 and estrogen synthesis pathway in skeletal tissues will be discusses as well as the biological significance of this interaction.

Keywords

References

  1. Khosla, S., Westendorf, J. J. and Oursler, M. J. (2008) Building bone to reverse osteoporosis and repair fractures. J. Clin. Invest. 118, 421-428. https://doi.org/10.1172/JCI33612
  2. Stein, G. S., Lian, J. B., van Wijnen, A. J., Stein, J. L., Montecino, M., Javed, A., Zaidi, S. K., Young, D. W., Choi, J. Y. and Pockwinse, S. M. (2004) Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 23, 4315-4329. https://doi.org/10.1038/sj.onc.1207676
  3. Choi, J. Y., Pratap, J., Javed, A., Zaidi, S. K., Xing, L., Balint, E., Dalamangas, S., Boyce, B., van Wijnen, A. J., Lian, J. B., Stein, J. L., Jones, S. N. and Stein, G. S. (2001) Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc. Natl. Acad. Sci. U.S.A. 98, 8650-8655. https://doi.org/10.1073/pnas.151236498
  4. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y. H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S. and Kishimoto, T. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764. https://doi.org/10.1016/S0092-8674(00)80258-5
  5. Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., Stamp, G. W., Beddington, R. S., Mundlos, S., Olsen, B. R., Selby, P. B. and Owen, M. J. (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771. https://doi.org/10.1016/S0092-8674(00)80259-7
  6. Banerjee, C., McCabe, L. R., Choi, J. Y., Hiebert, S. W., Stein, J. L., Stein, G. S. and Lian, J. B. (1997) Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J. Cell. Biochem. 66, 1-8. https://doi.org/10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V
  7. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. and Karsenty, G. (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754. https://doi.org/10.1016/S0092-8674(00)80257-3
  8. Javed, A., Barnes, G. L., Jasanya, B. O., Stein, J. L., Gerstenfeld, L., Lian, J. B. and Stein, G. S. (2001) runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins. Mol. Cell. Biol. 21, 2891-2905. https://doi.org/10.1128/MCB.21.8.2891-2905.2001
  9. Pratap, J., Javed, A., Languino, L. R., van Wijnen, A. J., Stein, J. L., Stein, G. S. and Lian, J. B. (2005) The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol. Cell. Biol. 25, 8581-8591. https://doi.org/10.1128/MCB.25.19.8581-8591.2005
  10. Zaidi, S. K., Javed, A., Choi, J. Y., van Wijnen, A. J., Stein, J. L., Lian, J. B. and Stein, G. S. (2001) A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J. Cell Sci. 114, 3093-3102.
  11. Han, M. S., Kim, H. J., Wee, H. J., Lim, K. E., Park, N. R., Bae, S. C., van Wijnen, A. J., Stein, J. L., Lian, J. B., Stein, G. S. and Choi, J. Y. (2010) The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-beta. J. Cell. Biochem. 110, 97-103.
  12. Kim, H. J., Nam, S. H., Kim, H. J., Park, H. S., Ryoo, H. M., Kim, S. Y., Cho, T. J., Kim, S. G., Bae, S. C., Kim, I. S., Stein, J. L., van Wijnen, A. J., Stein, G. S., Lian, J. B. and Choi, J. Y. (2006) Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype. J. Cell. Physiol. 207, 114-122. https://doi.org/10.1002/jcp.20552
  13. Mundlos, S., Otto, F., Mundlos, C., Mulliken, J. B., Aylsworth, A. S., Albright, S., Lindhout, D., Cole, W. G., Henn, W., Knoll, J. H., Owen, M. J., Mertelsmann, R., Zabel, B. U. and Olsen, B. R. (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773-779. https://doi.org/10.1016/S0092-8674(00)80260-3
  14. Pratap, J., Wixted, J. J., Gaur, T., Zaidi, S. K., Dobson, J., Gokul, K. D., Hussain, S., van Wijnen, A. J., Stein, J. L., Stein, G. S. and Lian, J. B. (2008) Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res. 68, 7795-7802. https://doi.org/10.1158/0008-5472.CAN-08-1078
  15. Zheng, Q., Zhou, G., Morello, R., Chen, Y., Garcia-Rojas, X. and Lee, B. (2003) Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J. Cell Biol. 162, 833-842. https://doi.org/10.1083/jcb.200211089
  16. Maruyama, Z., Yoshida, C. A., Furuichi, T., Amizuka, N., Ito, M., Fukuyama, R., Miyazaki, T., Kitaura, H., Nakamura, K., Fujita, T., Kanatani, N., Moriishi, T., Yamana, K., Liu, W., Kawaguchi, H., Nakamura, K. and Komori, T. (2007) Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev. Dyn. 236, 1876-1890. https://doi.org/10.1002/dvdy.21187
  17. Syed, F. and Khosla, S. (2005) Mechanisms of sex steroid effects on bone. Biochem. Biophys. Res. Commun. 328, 688-696. https://doi.org/10.1016/j.bbrc.2004.11.097
  18. Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K. S. and Simpson, E. R. (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337, 91-95. https://doi.org/10.1056/NEJM199707103370204
  19. Deladoey, J., Fluck, C., Bex, M., Yoshimura, N., Harada, N. and Mullis, P. E. (1999) Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy. J. Clin. Endocrinol. Metab. 84, 4050-4054. https://doi.org/10.1210/jc.84.11.4050
  20. Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C. and Qin, K. (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80, 3689-3698. https://doi.org/10.1210/jc.80.12.3689
  21. Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B. and Korach, K. S. (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331, 1056-1061. https://doi.org/10.1056/NEJM199410203311604
  22. Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., Nishina, H., Takeda, S., Takayanagi, H., Metzger, D., Kanno, J., Takaoka, K., Martin, T. J., Chambon, P. and Kato, S. (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811-823. https://doi.org/10.1016/j.cell.2007.07.025
  23. Martin-Millan, M., Almeida, M., Ambrogini, E., Han, L., Zhao, H., Weinstein, R. S., Jilka, R. L., O'Brien, C. A. and Manolagas, S. C. (2010) The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol. Endocrinol. 24, 323-334. https://doi.org/10.1210/me.2009-0354
  24. Park, H., Jung, Y. K., Park, O. J., Lee, Y. J., Choi, J. Y. and Choi, Y. (2005) Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis. J. Immunol. 175, 7193-7201. https://doi.org/10.4049/jimmunol.175.11.7193
  25. Krum, S. A., Miranda-Carboni, G. A., Hauschka, P. V., Carroll, J. S., Lane, T. F., Freedman, L. P. and Brown, M. (2008) Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J. 27, 535-545. https://doi.org/10.1038/sj.emboj.7601984
  26. Zallone, A. (2006) Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann. N. Y. Acad. Sci. 1068, 173-179. https://doi.org/10.1196/annals.1346.019
  27. Jones, M. E., Boon, W. C., Proietto, J. and Simpson, E. R. (2006) Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol. Metab. 17, 55-64. https://doi.org/10.1016/j.tem.2006.01.004
  28. Bulun, S. E., Sebastian, S., Takayama, K., Suzuki, T., Sasano, H. and Shozu, M. (2003) The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J. Steroid Biochem. Mol. Biol. 86, 219-224. https://doi.org/10.1016/S0960-0760(03)00359-5
  29. Simpson, E. R., Clyne, C., Rubin, G., Boon, W. C., Robertson, K., Britt, K., Speed, C. and Jones, M. (2002) Aromatase--a brief overview. Annu. Rev. Physiol. 64, 93-127. https://doi.org/10.1146/annurev.physiol.64.081601.142703
  30. Simpson, E. R., Mahendroo, M. S., Means, G. D., Kilgore, M. W., Hinshelwood, M. M., Graham-Lorence, S., Amarneh, B., Ito, Y., Fisher, C. R., Michael, M. D., Mendelson, C. R. and Bulun, S. E. (1994) Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 15, 342-355.
  31. Hinshelwood, M. M., Smith, M. E., Murry, B. A. and Mendelson, C. R. (2000) A 278 bp region just upstream of the human CYP19 (aromatase) gene mediates ovary-specific expression in transgenic mice. Endocrinology 141, 2050-2053. https://doi.org/10.1210/en.141.6.2050
  32. Mahendroo, M. S., Means, G. D., Mendelson, C. R. and Simpson, E. R. (1991) Tissue-specific expression of human P-450 AROM. The promoter responsible for expression in adipose tissue is different from that utilized in placenta. J. Biol. Chem. 266, 11276-11281.
  33. Mahendroo, M. S., Mendelson, C. R. and Simpson, E. R. (1993) Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J. Biol. Chem. 268, 19463-19470.
  34. Zhao, Y., Mendelson, C. R. and Simpson, E. R. (1995) Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes. Mol. Endocrinol. 9, 340-349. https://doi.org/10.1210/me.9.3.340
  35. Pezzi, V., Mathis, J. M., Rainey, W. E. and Carr, B. R. (2003) Profiling transcript levels for steroidogenic enzymes in fetal tissues. J. Steroid Biochem. Mol. Biol. 87, 181-189. https://doi.org/10.1016/j.jsbmb.2003.07.006
  36. Nawata, H., Tanaka, S., Tanaka, S., Takayanagi, R., Sakai, Y., Yanase, T., Ikuyama, S. and Haji, M. (1995) Aromatase in bone cell: association with osteoporosis in postmenopausal women. J. Steroid Biochem. Mol. Biol. 53, 165-174. https://doi.org/10.1016/0960-0760(95)00031-T
  37. Oz, O. K., Millsaps, R., Welch, R., Birch, J. and Zerwekh, J. E. (2001) Expression of aromatase in the human growth plate. J. Mol. Endocrinol. 27, 249-253. https://doi.org/10.1677/jme.0.0270249
  38. Sasano, H., Uzuki, M., Sawai, T., Nagura, H., Matsunaga, G., Kashimoto, O. and Harada, N. (1997) Aromatase in human bone tissue. J. Bone Miner Res. 12, 1416-1423. https://doi.org/10.1359/jbmr.1997.12.9.1416
  39. Shozu, M. and Simpson, E. R. (1998) Aromatase expression of human osteoblast-like cells. Mol. Cell. Endocrinol. 139, 117-129. https://doi.org/10.1016/S0303-7207(98)00069-0
  40. Tanaka, S., Haji, M., Nishi, Y., Yanase, T., Takayanagi, R. and Nawata, H. (1993) Aromatase activity in human osteoblast- like osteosarcoma cell. Calcif. Tissue Int. 52, 107-109. https://doi.org/10.1007/BF00308318
  41. Sjogren, K., Lagerquist, M., Moverare-Skrtic, S., Andersson, N., Windahl, S. H., Swanson, C., Mohan, S., Poutanen, M. and Ohlsson, C. (2009) Elevated aromatase expression in osteoblasts leads to increased bone mass without systemic adverse effects. J. Bone Miner Res. 24, 1263-1270. https://doi.org/10.1359/jbmr.090208
  42. Lea, C. K., Ebrahim, H., Tennant, S. and Flanagan, A. M. (1997) Aromatase cytochrome P450 transcripts are detected in fractured human bone but not in normal skeletal tissue. Bone 21, 433-440. https://doi.org/10.1016/S8756-3282(97)00168-3
  43. Shozu, M., Zhao, Y. and Simpson, E. R. (2000) TGF-beta1 stimulates expression of the aromatase (CYP19) gene in human osteoblast-like cells and THP-1 cells. Mol. Cell. Endocrinol. 160, 123-133. https://doi.org/10.1016/S0303-7207(99)00233-6
  44. Watanabe, M., Ohno, S. and Nakajin, S. (2005) Forskolin and dexamethasone synergistically induce aromatase (CYP19) expression in the human osteoblastic cell line SV-HFO. Eur. J. Endocrinol. 152, 619-624. https://doi.org/10.1530/eje.1.01882
  45. Watanabe, M., Simpson, E. R., Pathirage, N., Nakajin, S. and Clyne, C. D. (2004) Aromatase expression in the human fetal osteoblastic cell line SV-HFO. J. Mol. Endocrinol. 32, 533-545. https://doi.org/10.1677/jme.0.0320533
  46. Morioka, M., Shimodaira, K., Kuwano, Y., Fujikawa, H., Saito, H. and Yanaihara, T. (2000) Effect of interleukin-1beta on aromatase activity and cell proliferation in human osteoblast- like cells (HOS). Biochem. Biophys. Res. Commun. 268, 60-64. https://doi.org/10.1006/bbrc.1999.2063
  47. Enjuanes, A., Garcia-Giralt, N., Supervia, A., Nogues, X., Mellibovsky, L., Carbonell, J., Grinberg, D., Balcells, S. and Diez-Perez, A. (2003) Regulation of CYP19 gene expression in primary human osteoblasts: effects of vitamin D and other treatments. Eur. J. Endocrinol. 148, 519-526. https://doi.org/10.1530/eje.0.1480519
  48. Tanaka, S., Haji, M., Takayanagi, R., Tanaka, S., Sugioka, Y. and Nawata, H. (1996) 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts. Endocrinology 137, 1860-1869. https://doi.org/10.1210/en.137.5.1860
  49. Jeong, J. H., Jung, Y. K., Kim, H. J., Jin, J. S., Kim, H. N., Kang, S. M., Kim, S. Y., van Wijnen, A. J., Stein, J. L., Lian, J. B., Stein, G. S., Kato, S. and Choi, J. Y. (2010) The gene for aromatase, a rate-limiting enzyme for local estrogen biosynthesis, is a downstream target gene of Runx2 in skeletal tissues. Mol. Cell. Biol. 30, 2365-2375. https://doi.org/10.1128/MCB.00672-09
  50. Miyaura, C., Toda, K., Inada, M., Ohshiba, T., Matsumoto, C., Okada, T., Ito, M., Shizuta, Y. and Ito, A. (2001) Sex- and age-related response to aromatase deficiency in bone. Biochem. Biophys. Res. Commun. 280, 1062-1068. https://doi.org/10.1006/bbrc.2001.4246
  51. Oz, O. K., Hirasawa, G., Lawson, J., Nanu, L., Constantinescu, A., Antich, P. P., Mason, R. P., Tsyganov, E., Parkey, R. W., Zerwekh, J. E. and Simpson, E. R. (2001) Bone phenotype of the aromatase deficient mouse. J. Steroid Biochem. Mol. Biol. 79, 49-59. https://doi.org/10.1016/S0960-0760(01)00130-3
  52. Oz, O. K., Zerwekh, J. E., Fisher, C., Graves, K., Nanu, L., Millsaps, R. and Simpson, E. R. (2000) Bone has a sexually dimorphic response to aromatase deficiency. J. Bone Miner Res. 15, 507-514.
  53. Phillips, J. E., Gersbach, C. A., Wojtowicz, A. M. and Garcia, A. J. (2006) Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J. Cell Sci. 119, 581-591. https://doi.org/10.1242/jcs.02758
  54. Paredes, R., Arriagada, G., Cruzat, F., Villagra, A., Olate, J., Zaidi, K., van Wijnen, A., Lian, J. B., Stein, G. S., Stein, J. L. and Montecino, M. (2004) Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol. Cell. Biol. 24, 8847-8861. https://doi.org/10.1128/MCB.24.20.8847-8861.2004
  55. Khalid, O., Baniwal, S. K., Purcell, D. J., Leclerc, N., Gabet, Y., Stallcup, M. R., Coetzee, G. A. and Frenkel, B. (2008) Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer. Endocrinology 149, 5984-5995. https://doi.org/10.1210/en.2008-0680
  56. Teplyuk, N. M., Galindo, M., Teplyuk, V. I., Pratap, J., Young, D. W., Lapointe, D., Javed, A., Stein, J. L., Lian, J. B., Stein, G. S. and van Wijnen, A. J. (2008) Runx2 regulates G protein- coupled signaling pathways to control growth of osteoblast progenitors. J. Biol. Chem. 283, 27585-27597. https://doi.org/10.1074/jbc.M802453200
  57. Teplyuk, N. M., Zhang, Y., Lou, Y., Hawse, J. R., Hassan, M. Q., Teplyuk, V. I., Pratap, J., Galindo, M., Stein, J. L., Stein, G. S., Lian, J. B. and van Wijnen, A. J. (2009) The osteogenic transcription factor runx2 controls genes involved in sterol/ steroid metabolism, including CYP11A1 in osteoblasts. Mol. Endocrinol. 23, 849-861. https://doi.org/10.1210/me.2008-0270
  58. Jeong, J. H., Jin, J. S., Kim, H. N., Kang, S. M., Liu, J. C., Lengner, C. J., Otto, F., Mundlos, S., Stein, J. L., van Wijnen, A. J., Lian, J. B., Stein, G. S. and Choi, J. Y. (2008) Expression of Runx2 transcription factor in non-skeletal tissues, sperm and brain. J. Cell. Physiol. 217, 511-517. https://doi.org/10.1002/jcp.21524

Cited by

  1. Role of RUNX2 in Breast Carcinogenesis vol.16, pp.9, 2015, https://doi.org/10.3390/ijms160920969
  2. Fibroblast growth factor-7 facilitates osteogenic differentiation of embryonic stem cells through the activation of ERK/Runx2 signaling vol.382, pp.1-2, 2013, https://doi.org/10.1007/s11010-013-1716-5
  3. X-ray radiation at low doses stimulates differentiation and mineralization of mouse calvarial osteoblasts vol.45, pp.10, 2012, https://doi.org/10.5483/BMBRep.2012.45.10.101
  4. Periodontal Fibroblasts Modulate Proliferation and Osteogenic Differentiation of Embryonic Stem Cells Through Production of Fibroblast Growth Factors vol.85, pp.4, 2014, https://doi.org/10.1902/jop.2013.130252
  5. RUNX2: A Master Bone Growth Regulator That May Be Involved in the DNA Damage Response vol.34, pp.5, 2015, https://doi.org/10.1089/dna.2014.2688
  6. Fibroblast Growth Factor-4 Enhances Proliferation of Mouse Embryonic Stem Cells via Activation of c-Jun Signaling vol.8, pp.8, 2013, https://doi.org/10.1371/journal.pone.0071641
  7. The temporal expression of estrogen receptor alpha-36 and runx2 in human bone marrow derived stromal cells during osteogenesis vol.453, pp.3, 2014, https://doi.org/10.1016/j.bbrc.2014.09.111
  8. Overexpression of Runt-Related Transcription Factor-2 Is Associated with Advanced Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer vol.2012, 2012, https://doi.org/10.1155/2012/456534
  9. KLF2 regulates osteoblast differentiation by targeting of Runx2 pp.1530-0307, 2018, https://doi.org/10.1038/s41374-018-0149-x